<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>27246291</identifier>
<setSpec>2253-8070</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Goñi Gironés, E</dc:author>
<dc:author>Lozano Martínez, M E</dc:author>
<dc:author>Camarero Salazar, A</dc:author>
<dc:author>Estébanez Estébanez, C</dc:author>
<dc:author>Sangrós Sahún, M J</dc:author>
<dc:description xml:lang="en">The development of hypophosphataemic osteomalacia has been linked with several treatments, mainly antiretroviral and intravenous iron administration. The frequency of the hypophosphataemia requires monitoring the phosphate after the administration of iron carboxymaltose. We describe a case of a woman with no calcium-phosphorous metabolism disorder, to whom this treatment was prescribed for anaemia due to menorrhagia and intolerance to oral iron. She started with oligoarticular pain, which was spreading with a significant functional loss. The relationship with the administration of intravenous iron was discovered when scintigraphic findings together with laboratory results led to a diagnosis of hypophosphataemic osteomalacia. The patient responded satisfactorily to treatment with phosphate both clinically and in the follow-up bone scintigraphy.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:subject>Hierro carboximaltosa</dc:subject>
<dc:subject>Hipofosfatemia</dc:subject>
<dc:subject>Bone scintigraphy</dc:subject>
<dc:subject>Hypophosphataemia</dc:subject>
<dc:subject>Osteomalacia</dc:subject>
<dc:subject>Ferric carboxymaltose</dc:subject>
<dc:subject>Gammagrafía ósea</dc:subject>
<dc:date>2016 Nov - Dec </dc:date>
<dc:title xml:lang="es">Osteomalacia hipofosfatémica sintomática secundaria a tratamiento con hierro carboximaltosa objetivada con gammagrafía ósea.</dc:title>
<dc:title xml:lang="en">Symptomatic hypophosphataemic osteomalacia secondary to the treatment with iron carboxymaltose detected in bone scintigraphy.</dc:title>
<dc:publisher>Revista espanola de medicina nuclear e imagen molecular</dc:publisher>
</metadata>
</record>
</pubmed-document>
